Stockscreener 앱 받기
116.80
1.20%
-1.42
시간 외 거래:
116.80
전일 마감가:
$118.22
열려 있는:
$115.57
하루 거래량:
344.78K
Relative Volume:
0.52
시가총액:
$3.77B
수익:
$747.14M
순이익/손실:
$-44.55M
주가수익비율:
-82.79
EPS:
-1.4108
순현금흐름:
$34.52M
1주 성능:
-4.89%
1개월 성능:
-9.08%
6개월 성능:
-32.80%
1년 성능:
+7.82%
1일 변동 폭
$112.98
$119.49
1주일 범위
$112.98
$122.47
52주 변동 폭
$92.52
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
명칭
Irhythm Holdings Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
116.80 | 3.77B | 747.14M | -44.55M | 34.52M | -1.4108 |
ABT
Abbott Laboratories
|
102.87 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
331.54 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.63 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.82 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.05 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-09-23 | 개시 | Evercore ISI | In-line |
| 2025-08-20 | 개시 | BofA Securities | Buy |
| 2025-05-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Holdings Inc 주식(IRTC)의 최신 뉴스
Q4 2025 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Holdings, Inc. (IRTC) reports $5.6M net income, 70.9% gross margin in Q4 2025 - msn.com
How The iRhythm Holdings (IRTC) Narrative Is Shifting With New Guidance And DOJ Overhang - Yahoo Finance
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC By Investing.com - Investing.com Canada
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now - TradingView
iRhythm Holdings, Inc. Files Form 8-K: Company Information, Stock Details, and SEC Filing Data for March 2026 - Minichart
iRhythm Holdings appoints KPMG as new auditor, dismisses PwC - Investing.com
iRhythm (IRTC) switches from PwC to KPMG as independent auditor - Stock Titan
Data Presented at ACC.26 Demonstrate Benefits of iRhythm's Zio Ambulatory ECG Portfolio - National Today
iRhythm Presents Data Demonstrating Zio Ambulatory ECG Benefits Across Patient Populations - National Today
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - Bitget
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - The Manila Times
Studies found frequent arrhythmias in diabetes, kidney and obesity patients - Stock Titan
Free cash flow per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Does New ACC.26 Data and AI Push Change The Bull Case For iRhythm Holdings (IRTC)? - Sahm
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
Jason Patten Joins iRhythm Holdings’ Board of Directors - Medical Product Outsourcing
Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC) - Stock Titan
Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC - MarketBeat
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - msn.com
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC) - Yahoo Finance
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund - The Globe and Mail
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund. - Bitget
iRhythm (IRTC) director granted 2,218 RSUs vesting from 2027 - Stock Titan
Director Jason H. Patten reports initial holdings in iRhythm Holdings (IRTC) - Stock Titan
How Investors Are Reacting To iRhythm Holdings (IRTC) Adding UnitedHealth Strategy Executive To Its Board - Sahm
iRhythm Holdings, Inc. (IRTC) Q4 earnings and revenues beat estimates - MSN
Insider Sell: Mervin Smith Sells Shares of iRhythm Holdings Inc (IRTC) - GuruFocus
iRhythm (NASDAQ: IRTC) EVP sells 2,585 shares under 10b5-1 plan - Stock Titan
Holocene Advisors LP Buys 160,186 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm appoints UnitedHealth executive to board - Investing.com Nigeria
Proposed sale of 2,585 performance shares by Mervin Smith (IRTC) - Stock Titan
Cinctive Capital Management LP Takes $4.82 Million Position in iRhythm Technologies $IRTC - MarketBeat
Algert Global LLC Increases Stake in iRhythm Technologies $IRTC - MarketBeat
A Look At iRhythm Holdings (IRTC) Valuation After Recent Share Price Weakness - simplywall.st
Final Deadline Approaching on April 2, 2021: Kessler Topaz Meltzer & Check, LLP Reminds iRhythm Technologies, Inc. Investors of Class Action Lawsuit Deadline - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Time To Revisit iRhythm Holdings (IRTC) After The Recent Share Price Slide? - simplywall.st
iRhythm appoints UnitedHealth executive to board By Investing.com - Investing.com Australia
Irhythm Technologies appoints Jason Patten to board - The Globe and Mail
Latest IRTC NewsiRhythm Technologies to Report Second Quart... - Stock Titan
Irhythm Holdings Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):